Targeting caspases in intracellular protozoan infections

Immunopharmacol Immunotoxicol. 2009 Jun;31(2):159-73. doi: 10.1080/08923970802332164.

Abstract

Caspases are cysteine aspartases acting either as initiators (caspases 8, 9, and 10) or executioners (caspases 3, 6, and 7) to induce programmed cell death by apoptosis. Parasite infections by certain intracellular protozoans increase host cell life span by targeting caspase activation. Conversely, caspase activation, followed by apoptosis of lymphocytes and other cells, prevents effective immune responses to chronic parasite infection. Here we discuss how pharmacological inhibition of caspases might affect the immunity to protozoan infections, by either blocking or delaying apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antiprotozoal Agents / immunology
  • Antiprotozoal Agents / therapeutic use*
  • Apoptosis / drug effects*
  • Apoptosis / immunology
  • Caspase Inhibitors*
  • Humans
  • Immune Tolerance / drug effects
  • Mice
  • Protozoan Infections / drug therapy*
  • Protozoan Infections / enzymology
  • Protozoan Infections / immunology
  • Receptors, Death Domain / immunology

Substances

  • Antiprotozoal Agents
  • Caspase Inhibitors
  • Receptors, Death Domain